![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
烯的抗癌作用:专注于恶性黑色素瘤
Paula Wróblewska-Łuczka1, Justyna Cabaj1, Julia Bargieł1
1Department of Occupational Medicine, Medical University of Lublin, Jaczewskiego 8B, 20-090, Lublin, Poland.
Pharmacological reports : PR
|July 29, 2023
概括
烯显示出作为自然抗癌药物对黑色素瘤的承诺. 本综述总结了它们在抑制瘤生长和诱导癌细胞死亡方面的潜力,提供了新的治疗途径.
科学领域:
- 自然产品化学 自然产品化学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 黑色素瘤是一种侵袭性皮肤癌,常规治疗疗效有限.
- 治疗耐药性和副作用需要新的治疗策略.
- 烯是植物衍生化合物,具有抗癌性质.
研究的目的:
- 审查各种烯的抗癌作用.
- 专注于烯在恶性黑色素瘤的治疗潜力.
主要方法:
- 关于烯和黑色素瘤的科学研究的文献评论.
- 对烯机制的分析,包括瘤抑制和亡诱导.
主要成果:
- 烯在抑制黑色素瘤细胞增殖方面显示出显著的潜力.
- 特定的烯,如蒂莫金,β-元素和利蒙,显示出有前途的抗癌活性.
- 烯可以诱导黑色素瘤细胞的亡,这表明有针对性的癌症细胞死亡.
结论:
- 烯代表了一类有希望的天然化合物用于黑色素瘤治疗.
- 对基于烯的治疗方法的进一步研究可能会导致更有效,更少毒性的黑色素瘤治疗方法.
- 审查的烯具有作为针对恶性黑色素瘤的新型治疗剂的潜力.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
01:27Tumor Immunotherapy
558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558
01:30Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K